Format

Send to

Choose Destination
Eur J Obstet Gynecol Reprod Biol. 2019 Jan;232:33-39. doi: 10.1016/j.ejogrb.2018.10.009. Epub 2018 Oct 6.

Long-term (8.5 years) analysis of the type and rate of reoperation after transvaginal mesh repair (Prolift®) in 349 patients.

Author information

1
CHRU Jeanne de Flandre, Lille, France. Electronic address: oceane-pecheux@hotmail.fr.
2
CHRU Jeanne de Flandre, Lille, France.
3
Department of Biostatistics, Univ. Lille, CHU Lille, EA 2694 - Santé publique: épidémiologie et qualité des soins, F-59000, Lille, France. Electronic address: marcdiserio@gmail.com.
4
FMH en Gynécologie et Obstétrique Hôpital du Valais, Sion, Switzerland. Electronic address: Estelleestelle.jeanditgautier@chru-lille.fr.
5
Department of Obstetrics and Gynecology, University of Liège, CHR La Citadelle, Boulevard du 12e de Ligne, n°1, 4000, Liège, Belgium.
6
CHRU Jeanne de Flandre, Lille, France. Electronic address: michel.cosson@chru-lille.fr.

Abstract

OBJECTIVE:

Polypropylene meshes have specific complications, and in 2016 the Food and Drug Administration required a Premarket Approval for their use in pelvic prolapse repair, as there was a lack of long-term data. Our objectives were to determine the long-term reoperation rates and type in our patients after transvaginal mesh repair and to study their risk factors.

STUDY DESIGN:

We were able to follow up with 349 patients from a single University Hospital, with phone calls, after a median time of 8,5 years. The 8.5-year reoperation rates were derived from Kaplan-Meier survival curves.

RESULTS:

Our global, long-term reoperation rate, including mesh complications, prolapse recurrence and urinary incontinence after a median follow-up of 8.5 years, was 14.5%. The mesh-related complication rate (including mesh exposures, infections, and retractions requiring surgery) was 4.3%, the urinary incontinence rate was 5.7%. The prolapse recurrence rate was 7.2%; mainly found with posterior mesh only (18.5% of reoperations). For total Prolift, the reoperation rate for prolapse recurrence was only 4%. Moreover, 867% of the patients who had an anterior Prolift only or a posterior Prolift only and who were re-operated for prolapse recurrence showed recurrence exclusively in another compartment. In bivariate analysis, only the posterior mesh type was significantly associated with prolapse recurrence versus total meshes.

CONCLUSION:

Despite their market withdrawal, the transvaginal meshes are a safe and efficient option for pelvic organ prolapse surgical management. Low rates of mesh complications can be achieved with cautious dissection and adequate training of surgeons.

KEYWORDS:

Exposure; Mesh; POP (pelvic organ prolapse); Prolift; Recurrence

PMID:
30465929
DOI:
10.1016/j.ejogrb.2018.10.009
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center